Putting the pieces together: what families and care teams should know about CDPX1
Paediatrician Dr Tayyaba Niaz Awan explains why she wrote a new, free-to-read review of X-linked chondrodysplasia punctata 1, and the practical steps she hopes every family and care team will take

Written by Dr Tayyaba Niaz Awan, MBBS, FCPS (Paediatrics)
As a paediatrician, I have spent much of my career explaining test results to worried parents. I have sketched chromosomes on scraps of paper, answered questions late into the evening and promised families that we would find a way forward together. With common conditions, that promise is easier to keep. With rare conditions, it can be very hard, because the information families need is often missing, scattered or written only for specialists.
That gap is why I wrote a new review on X-linked chondrodysplasia punctata 1, usually shortened to CDPX1.
What is CDPX1?
CDPX1 is a rare genetic condition that mainly affects boys. It is caused by changes in the ARSL gene on the X chromosome, which is important for normal cartilage and bone development. Babies with CDPX1 often have tiny spots of calcium in the cartilage of their growing bones. These show up on X-rays and give the condition its name: punctata means spotted. Many children also have a flatter nose and midface, short fingertips and shorter height.
In some children, CDPX1 happens because a small piece of the X chromosome is missing. This is called an Xp22.33 deletion. When a piece is missing, more than one gene can be lost at the same time. That is where the picture becomes more complicated and where families most often struggle to get clear answers.
Scattered answers
When I began reading about CDPX1, what I found was scattered: single case reports, small family studies and articles written for specialists in different fields. Nothing brought it all together. Nothing explained, in one place, why one boy with CDPX1 might have only bone differences while another also has autism and language delay. And nothing gave families and care teams a clear plan.
Why the size of the missing piece matters
The more I read, the clearer one pattern became. Whether a child has developmental differences seems to depend on how large the missing piece is and which genes sit inside it. One of the key genes is NLGN4X, which helps nerve cells in the brain connect and communicate. When a deletion also includes NLGN4X, children are more likely to have autism, language delay, coordination difficulties and sensory differences.
This matters enormously for families. A genetic test result can show not only that a child has CDPX1, but also which kinds of support they may need, often before the signs are obvious. Families can then be offered help early, instead of waiting for difficulties to appear.
Bringing it together
The review, published this autumn in the Orphanet Journal of Rare Diseases, is free for anyone to read. It brings together what is known about the genetics of CDPX1 and Xp22.33 deletions, how the condition looks in different children, the neurodevelopmental features linked to larger deletions and how care teams can work together.
I wrote it with two audiences in mind. For professionals, it gathers the evidence in one place. For families, I hope it offers something just as important: the knowledge that their questions have answers, and the words to ask for the right tests and support.
What I want families and care teams to know
If your child has CDPX1, or you care for a child who does, these are the practical points I hope you take away.
- Ask about the size of the deletion. A test called a chromosomal microarray can show whether a piece of the X chromosome is missing and how big it is. This helps show which genes are involved
- Ask for an early developmental assessment. Please don’t wait and see. If the deletion includes NLGN4X, or you notice delays in speech, play or movement, an early assessment can open the door to support
- Ask about early intervention. Support for communication, movement and daily skills can start in the first years of life, while the brain is developing quickly
- Tell the anaesthetic team before any procedure. Some children with CDPX1 have a narrower airway or differences in the bones of the neck. A simple conversation beforehand helps keep surgery and scans safe
- Build a team around your child. Children with CDPX1 may see geneticists, developmental paediatricians, therapists, orthopaedic specialists, ear, nose and throat doctors and more. Ask who will coordinate care and keep your own summary of results to share at each appointment
Why this matters
Rare diseases are rare one by one, but together they affect millions of families. Every one of those families deserves a clear, kind explanation of what a diagnosis means. As paediatricians, we cannot always offer a cure, but we can offer good information, early support and a plan.
If this review helps even one family find answers sooner, or helps one care team plan ahead, it will have done its job.
Read the full review, free of charge
Awan TN. X-linked chondrodysplasia punctata 1 (CDPX1) due to ARSL pathogenic variants and Xp22.33 contiguous gene deletions: a narrative review of genetics, clinical phenotype, neurodevelopmental features, diagnosis, and multidisciplinary management. Orphanet Journal of Rare Diseases, 2026. https://doi.org/10.1186/s13023-026-04648-0
About the author
Dr Tayyaba Niaz Awan is a paediatrician (MBBS, FCPS Paediatrics) based in Aberdeen, Idaho, USA. Her new review of CDPX1 aims to help families and care teams understand this rare genetic condition.